Clinical characteristics of inflammatory bowel disease in Turkey: A multicenter epidemiologic survey

Journal of Clinical Gastroenterology

Volumn 43, Issue 1, 2009, Pages 51-57

  Tozun, Nurdan ^a   Atug, Ozlen ^a   Imeryuz, Nese ^a   Hamzaoglu, Hulya O ^a   Tiftikci, Arzu ^a   Parlak, Erkan ^c   Dagli, Ulku ^c   Ulker, Aysel ^c   Hulagu, Sadettin ^g   Akpinar, Hale ^h   Tuncer, Candan ^d   Suleymanlar, Inci ⁱ   Ovunc, Oya ^b   Hilmioglu, Fatih ^j   Aslan, Serap ^e   Turkdogan, Kursat ^k   Bahcecioglu, Halil Ibrahim ^l   Yurdaydin, Cihan ^f   Barghi, I ^a   Senturk, O ^g   Simsek, I ^h   Dogan, I ^d   Akca, S ⁱ   Ebut, E ^b   Aladag, M ^j   Kav, T ^e   Tuncer, I ^k   more..

^a MARMARA UNIVERSITY   (Turkey)

^b GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^c Department of Gastroenterology   (Turkey)

^d GAZI UNIVERSITY   (Turkey)

^e HACETTEPE UNIVERSITY   (Turkey)

^f ANKARA UNIVERSITY   (Turkey)

^g KOCAELI UNIVERSITY   (Turkey)

^h DOKUZ EYLUL UNIVERSITY   (Turkey)

ⁱ AKDENIZ UNIVERSITY   (Turkey)

^j INONU UNIVERSITY   (Turkey)

^k YUZUNCU YIL UNIVERSITY   (Turkey)

^l FIRAT UNIVERSITY   (Turkey)

more..

Author keywords

Crohn's disease; Epidemiology; Inflammatory bowel disease; Turkey; Ulcerative colitis

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AMEBIASIS; APPENDECTOMY; ARTHRITIS; ARTICLE; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; FAMILY HISTORY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; QUESTIONNAIRE; TURKEY (REPUBLIC); ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AMEBIASIS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; SMOKING; TURKEY; YOUNG ADULT;

EID: 67651180688     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181574636     Document Type: Article

References (83)

1. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2006;12(suppl 1):S3-S9. (Pubitemid 43068428)
2. Sands BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology. 2004;126:1518-1532.
3. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-429.
4. Calkins M, Mendeloff AI. Epidemiology of inflammatory bowel disease. Epidemiol Rev. 1986;8:60-91.
5. Colombel JF. Introduction. Emergent issues in inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2003;17:1-2.
6. Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut. 1996;39:690-697. (Pubitemid 26426470)
7. Logan RFA. Inflammatory bowel disease incidence: up, down, or unchanged? Gut. 1998;42:309-311.
8. Loftus EV Jr, Silverstein MD, Sandborn WJ. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology. 1998;114:1161-1166.
9. Loftus EV Jr, Silverstein MD, Sandborn WJ, et al. Ulcerative colitis in Olmsted county, Minnesota 1940-1993: incidence, prevalence, and survival. Gut. 2000;46:336-343.
10. Loftus EV, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:1-20.
11. Sinclair TS, Brunt PW, Mowat NAG. Nonspecific proctocolitis in Northeastern Scotland: a community study. Gastroenterology. 1983;85:1-11.
12. Haug K, Nordgaard K, Aronsen O, et al. Epidemiology of ulcerative colitis in western Norway. Scand J Gastroenterol. 1988;23:517-522. (Pubitemid 18165986)
13. Tragnone A, Corrao G, Miglio F, et al. Incidence of inflammatory bowel disease in Italy: a nationwide population- based study. Int J Epidemiol. 1996;25:1044-1052. (Pubitemid 26348685)
14. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology. 1991;100:143-149.
15. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28:255-281. (Pubitemid 29306479)
16. Sandler RS, Loftus EV Jr. Epidemiology of inflammatory bowel disease. In: Sartor RB, SandbornWJ, eds. Kirsner's Inflammatory Bowel Diseases. 6th ed. Philadelphia, PA: WB Saunders; 2004: 245-262.
17. Roth MP, Petersen GM, McElree C, et al. Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology. 1989;97:900-904. (Pubitemid 19239027)
18. Kurata JH, Kanto-Fish S, Frankl H, et al. Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology. 1992;102:1940-1948.
19. Sonnenberg A, Wasserman IH. Epidemiology of inflammatory bowel disease among U.S. military veterans. Gastroenterology. 1991;101:122-130.
20. Yang S-K, Loftus EV, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001;7: 260-270. (Pubitemid 32776521)
21. Carr I, Mayberry JF. The effects of migration on ulcerative colitis: a three year prospective study among Europeans and first- and second-generation South Asians in Leicester (1991-1994). Am J Gastroenterol. 1999;94:2918-2922.
22. Ulker A, Parlak E, Dagli U, et al. Epidemiology of inflammatory bowel disease. Turk J Gastroenterol. 1999;10:55-59.
23. Tezel A, Dokmeci G, Eskiocak M, et al. Epidemiological features of ulcerative colitis in Trakya, Turkey. J Int Med Res. 2003;31:141-148. (Pubitemid 36553313)
24. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989;24(suppl):2-6.
25. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 1991;325:928-940.
26. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. BMJ. 1955;2:1041-1048.
27. Riddell RH. Pathology of idiopathic inflammatory bowel disease. In: Kirshner JB, ed. Inflammatory Bowel Disease. Philadelphia: WB Saunders; 2000:427-439.
28. Whelan G. Epidemiology of inflammatory bowel disease. Med Clin North Am. 1990;74:1-12.
29. Jovanovic Z. Epidemiology of Crohn's disease in the Rijeka- Istra region [in Serbo-Croatian]. Lijec Vjesn. 1999;121:8-13.
30. Anseline PF. Crohn's disease in the Hunter Valley region of Australia. Aust N Z J Surg. 1995;65:564-569.
31. Stone MA, Mayberry JF, Baker R. Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol. 2003;15: 1275-1280. (Pubitemid 39049669)
32. Rubin GP, Hungin AP, Kelly PJ, et al. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther. 2000;14: 1553-1559.
33. Daiss W, Scheurlen M, Malchow H. Epidemiology of inflammatory bowel disease in the county of Tubingen (West Germany). Scand J Gastroenterol. 1989;170:39-43. (Pubitemid 20015821)
34. Gower-Rousseau C, Salomez JL, Dupas JL, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut. 1994;35:1433-1438.
35. Stowe SP, Redmond SR, Stormont JM, et al. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology. 1990;98:104-110.
36. Ekbom A, Helmick C, Zack M, et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991; 100:350-358.
37. Cottone M, Cipolla C, Orlando A, et al. Epidemiology of Crohn's disease in Sicily: a hospital incidence study from 1987 to 1989. The Sicilian Study Group of Inflammatory Bowel Disease. Eur J Epidemiol. 1991;7:636-1340
38. Manousos ON, Koutroubakis I, Potamianos S, et al. A prospective epidemiologic study of Crohn's disease in Heraklion, Crete: incidence over a 5-year period. Scand J Gastroenterol. 1996;31:599-603. (Pubitemid 26196142)
39. Ruiz V. Crohn's disease in Galicia, Spain. Scand J Gastroenterol Suppl. 1989;170:29-31; discussion 50-55.
40. Trallori G, Palli D, Saieva C, et al. A population-based study of inflammatory bowel disease in Florence over 15 years (1978-1992). Scand J Gastroenterol. 1996;31:892-899.
41. Gilat T, Hacohen D, Lilos P, et al. Childhood factors in ulcerative colitis and Crohn's disease. Scand J Gastroenterol. 1987;22:1009-1024.
42. Regueiro M, Kip KE, Cheung O, et al. Cigarette smoking and age at diagnosis of inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:42-47. (Pubitemid 40340255)
43. Krishnan A, Korzenik JR. Inflammatory bowel disease and environmental influences. Gastroenterol Clin North Am. 2002;31: 21-39. (Pubitemid 34733031)
44. Lindberg E, Tysk C, Andersson K, et al. Smoking and inflammatory bowel disease: a case control study. Gut. 1988;29: 352-357. (Pubitemid 18082152)
45. Merrett MN, Mortensen N, Kettlewell M, et al. Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut. 1996;38:362-364. (Pubitemid 26074315)
46. Boyko EJ, Perera DR, Koepsell TD, et al. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol. 1988;23:1147-1152.
47. Monsen U, Brostrom O, Nordenvall B, et al. Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis. Scand Gastroenterol. 1987;22:214-218. (Pubitemid 17024407)
48. Yang H, McElree C, Roth MP, et al. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut. 1993;34:517-524. (Pubitemid 23093496)
49. Farmer RG, Michener WM, Mortimer EA. Studies of family history among patients with inflammatory bowel disease. Clin Gastroenterol. 1980;9:271-277.
50. Vessey M, Jewell D, Smith A, et al. Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of childbearing age. BMJ. 1986;292:1101-1103. (Pubitemid 16110633)
51. Lesko SM, Kaufman DW, Rosenberg L, et al. Evidence for an increased risk of Crohn's disease in oral contraceptive users. Gastroenterology. 1985;89:1046-11019 (Pubitemid 16231568)
52. Lashner BA, Kane SV, Hanauer SB. Lack of association between oral contraceptive use and Crohn's disease: a community-based matched case-control study. Gastroenterology. 1989;97:1442-1447.
53. Lashner BA, Kane SV, Hanauer SB. Lack of association between oral contraceptive use and ulcerative colitis. Gastroenterology. 1990;99:1032-1036.
54. Katschinski B, Fingerle D, Scherbaum B, et al. Oral contraceptive use and cigarette smoking in Crohn's disease. Dig Dis Sci. 1993;38:1596-1600. (Pubitemid 23271412)
55. Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut. 1995;37:668-673.
56. Boyko EJ, Theis MK, Vaughan TL, et al. Increased risk of inflammatory bowel disease associated with oral contraceptive use. Am J Epidemiol. 1994;140:268-278.
57. Rutgeerts P, D'Haens G, Hiele M, et al. Appendectomy protects against ulcerative colitis. Gastroenterology. 1994;106:1251-1253. (Pubitemid 24129241)
58. Radford-Smith GL. The role of the appendix and appendectomy in patients with IBD. IBD Monitor. 2003;4:120-128.
59. Koutroubakis IE, Vlachonikolis IG, Kouroumalis EA. Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm Bowel Dis. 2002;8:277-286. (Pubitemid 34784981)
60. Andersson RE, Olaison G, Tysk C, et al. Appendectomy and protection against ulcerative colitis. N Engl J Med. 2001;344: 808-814. (Pubitemid 32222158)
61. Frisch M, Johansen C, Mellemkjaer L, et al. Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery. 2001;130:36-43. (Pubitemid 32626195)
62. Gheorghea C, Pascub O, Gheorghea L, et al. Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: a multicentre study. Eur J Gastroenterol Hepatol. 2004;16:1153-1159.
63. Wiercinska-Drapalo A, Jaroszewicz J, Flisiak R, et al. Epidemiological characteristics of inflammatory bowel disease in North-Eastern Poland.World J Gastroenterol. 2005;11:2630-2633.
64. Yang S-K, Hong W-S, Min YI, et al. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong district, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol. 2000;15:1037-1042.
65. Aghazadeh R, Zali MR, Bahari A, et al. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol. 2005;20:1691-1695. (Pubitemid 43961074)
66. Dekker-Saeys BJ, Meuwissen SGM, Van Den Berg-Loonen EM, et al. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease. Ann Rheum Dis. 1978;37:36-41. (Pubitemid 8371821)
67. Weiner SR, Clarke J, Taggart NA, et al. Rheumatic manifestations of inflammatory bowel disease. Semin Arth Rheum. 1991;20: 353-366.
68. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut. 1998;42:387-391.
69. Lindgren A, Wallerstedt S, Olsson R. Prevalence of Crohn's disease and simultaneous occurrence of extraintestinal complications and cancer. An epidemiologic study in adults. Scand J Gastroenterol. 1996;31:74-78. (Pubitemid 126423304)
70. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976;55: 401-412.
71. Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evaluation of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol. 1985;80:615-620.
72. Aitola P, Matikainen M, Mattila J. Hepatobiliary changes in patients with ulcerative colitis, with special reference to the effect of proctocolectomy. Scand J Gastroenterol. 1998;33: 113-117. (Pubitemid 28098222)
73. Hopkins DJ, Horan E, Burton IL, et al. Ocular disorders in a series of 332 patients with Crohn's disease. Brit J Ophthal. 1974;58:732-737.
74. Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut. 2004;53:542-548.
75. Bargiggia S, Maconi G, Elli M, et al. Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center. J Clin Gastroenterol. 2003;36:417-420. (Pubitemid 36459139)
76. Fraquelli M, Losco A, Visentin S, et al. Gallstone disease and related risk factors in patients with Crohn disease: analysis of 330 consecutive cases. Arch Intern Med. 2001;8: 2201-2214. (Pubitemid 32905000)
77. Lapidus A, Bangstad M, Astrom M, et al. The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease. Am J Gastroenterol. 1999;94:1261-1266. (Pubitemid 29214639)
78. Hutchinson R, Tyrrell PN, Kumar D, et al. Pathogenesis of gall stones in Crohn's disease: an alternative explanation. Gut. 1994;35: 94-97. (Pubitemid 24059480)
79. Lorusso D, Leo S, Mossa A, et al. Cholelithiasis in inflammatory bowel disease. A case-control study. Dis Colon Rectum. 1990;33:791-794.
80. Schölmerich J, Braun G, Volk BA, et al. Detection of extraintestinal and intestinal abnormalities in inflammatory bowel disease by ultrasound. Dig Surg. 1987;4:82-87.
81. Kangas E, Lehmusto P, Matikainen M. Gallstones in Crohn's disease. Hepatogastroenterology. 1990;37:83-84.
82. Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centers. Gut. 1988;29:206-217. (Pubitemid 18078890)
83. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Eng J Med. 1990;323:1228-1233. (Pubitemid 20366527)